These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 288324)

  • 1. Studies on the role of acetylhydrazine in isoniazid hepatotoxicity.
    Timbrell JA
    Arch Toxicol Suppl; 1979; (2):1-8. PubMed ID: 288324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the effects of isoniazid on acetylhydrazine metabolism in vivo and in vitro.
    Timbrell JA; Wright JM
    Drug Metab Dispos; 1979; 7(4):237-40. PubMed ID: 39727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the metabolism of [14C]acetylhydrazine in rats.
    Wright JM; Timbrell JA
    Drug Metab Dispos; 1978; 6(5):561-6. PubMed ID: 30606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylation of acetylhydrazine, the toxic metabolite of isoniazid, in humans. Inhibition by concomitant administration of isoniazid.
    Peretti E; Karlaganis G; Lauterburg BH
    J Pharmacol Exp Ther; 1987 Nov; 243(2):686-9. PubMed ID: 3681700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid hepatoxicity: the relationship between covalent binding and metabolism in vivo.
    Timbrell JA; Mitchell JR; Snodgrass WR; Nelson SD
    J Pharmacol Exp Ther; 1980 May; 213(2):364-9. PubMed ID: 6767840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoacetylhydrazine as a metabolite of isoniazid in man.
    Timbrell JA; Wright JM; Baillie TA
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):602-8. PubMed ID: 913027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation of hydrazine metabolites formed from isoniazid.
    Lauterburg BH; Smith CV; Todd EL; Mitchell JR
    Clin Pharmacol Ther; 1985 Nov; 38(5):566-71. PubMed ID: 3931954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
    Lauterburg BH; Smith CV; Todd EL; Mitchell JR
    J Pharmacol Exp Ther; 1985 Dec; 235(3):566-70. PubMed ID: 4078724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cimetidine inhibits the formation of the reactive, toxic metabolite of isoniazid in rats but not in man.
    Lauterburg BH; Todd EL; Smith CV; Mitchell JR
    Hepatology; 1985; 5(4):607-9. PubMed ID: 4018731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat.
    Nelson SD; Mitchell JR; Timbrell JA; Snodgrass WR; Corcoran GB
    Science; 1976 Sep; 193(4256):901-3. PubMed ID: 7838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of isoniazid administration on selected rat and mouse hepatic microsomal mixed-function oxidases and in vitro [14C]acetylhydrazine-derived covalent binding.
    Powell-Jackson PR; Tredger JM; Smith HM; Davis M; Williams R
    Biochem Pharmacol; 1982 Dec; 31(24):4031-4. PubMed ID: 7159479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of [14C]acetylisoniazid and [14C]acetylhydrazine by the rat and rabbit.
    Thomas BH; Whitehouse LW; Zeitz W
    Fundam Appl Toxicol; 1984 Aug; 4(4):646-53. PubMed ID: 6479511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylhydrazine hepatotoxicity: the role of covalent binding.
    Woodward KN; Timbrell JA
    Toxicology; 1984 Feb; 30(1):65-74. PubMed ID: 6701906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is isoniazid-hepatotoxicity induced by the metabolite, hydrazine?
    Noda A; Hsu KY; Noda H; Yamamoto Y; Kurozumi T
    J UOEH; 1983 Jun; 5(2):183-90. PubMed ID: 6679629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites.
    Mitchell JR; Thorgeirsson UP; Black M; Timbrell JA; Snodgrass WR; Potter WZ; Jollow HR; Keiser HR
    Clin Pharmacol Ther; 1975 Jul; 18(1):70-9. PubMed ID: 1149365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model.
    Tafazoli S; Mashregi M; O'Brien PJ
    Toxicol Appl Pharmacol; 2008 May; 229(1):94-101. PubMed ID: 18295292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of isoniazid, acetylisoniazid, acetylhydrazine and diacetylhydrazine in biological fluids by high-performance liquid chromatography.
    von Sassen W; Castro-Parra M; Musch E; Eichelbaum M
    J Chromatogr; 1985 Feb; 338(1):113-22. PubMed ID: 4019638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of metabolism in the hepatotoxicity of isoniazid and iproniazid.
    Timbrell JA
    Drug Metab Rev; 1979; 10(1):125-47. PubMed ID: 393481
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of rifampin, phenobarbital pretreatment, and acetylator phenotype on acetylisoniazid metabolism in the rabbit.
    Thomas BH; Zeitz W; Whitehouse LW
    Can J Physiol Pharmacol; 1987 Mar; 65(3):419-23. PubMed ID: 3580961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism-dependent inhibition of CYP2E1 by isoniazid, a mediator of idiosyncratic liver injury.
    Masubuchi Y; Miyauchi K
    Chem Biol Interact; 2024 Sep; 400():111160. PubMed ID: 39047805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.